St.Shine Optical Co.,Ltd. (TPEX:1565)
Taiwan
· Delayed Price · Currency is TWD 104.50
+1.00 (0.97%)
Apr 29, 2026, 1:30 PM CST
St.Shine Optical Revenue
In the year 2025, St.Shine Optical had annual revenue of 4.12B TWD, down -9.52%. St.Shine Optical had revenue of 942.47M in the quarter ending December 31, 2025, a decrease of -23.37%.
Revenue
4.12B
Revenue Growth
-9.52%
P/S Ratio
1.27
Revenue / Employee
1.11M
Employees
3,698
Market Cap
5.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.12B | -433.20M | -9.52% |
| Dec 31, 2024 | 4.55B | 156.17M | 3.55% |
| Dec 31, 2023 | 4.39B | -609.61M | -12.18% |
| Dec 31, 2022 | 5.00B | -398.11M | -7.37% |
| Dec 31, 2021 | 5.40B | 395.02M | 7.89% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pacific Hospital Supply | 2.41B |
| Formosa Optical Technology | 4.13B |
| SciVision Biotech | 886.62M |
| Bionime | 1.84B |
| Nang Kuang Pharmaceutical | 2.16B |
| Medeon Biodesign | 419.43M |
| Maxigen Biotech | 811.56M |
| Bioteque | 2.14B |